To characterize the alterations of the cellular metabolism in order to intervene pharmacologically and prevent or reverse the progression of the SARS-CoV-2 infection. These alterations must be identified in order to identify which of them are essential for the reproduction of the virus and/or progression of the infection by establishing the use of drugs aimed at interfering with the identified routes of SARS-CoV-2 infection.
Principal Investigator: Francisco José Iborra (IBV)
